On October 24, 2019, the Food and Drug Evaluation and Inspection Center of Ningxia Hui Autonomous Region conducted a certification inspection on Qiyuan Pharmaceutical Co., Ltd. in accordance with the procedures prescribed by the Drug Administration Law of the People's Republic of China and its implementation regulations.

After the inspection, the company’s quality leadership team made a serious summary, actively sought out the reasons for the existing problems and defects, and carried out rectifications earnestly. The rectifications have now been completed. On November 14, the Autonomous Region Drug Administration issued the "Drug Business License" and the "Drug Business Quality Management Standard Certification Certificate" (GSP certificate) for the enterprise.

Since the establishment of Qiyuan Pharmaceutical Co., Ltd. and the implementation of GSP certification, the company has carried out drug business management in strict accordance with relevant laws and regulations, and strictly controlled potential risks in drug business through comprehensive internal audits, annual quality reviews, risk assessments, and change control. “Board”, taking multiple measures simultaneously to continuously improve management. Through this inspection and certification, the company's drug business quality management level has been promoted to a new level.